Lateritin

CAS No. 65454-13-9

Lateritin( Bassiatin )

Catalog No. M27818 CAS No. 65454-13-9

Lateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 578 Get Quote
10MG 822 Get Quote
25MG 1233 Get Quote
50MG 1665 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lateritin
  • Note
    Research use only, not for human use.
  • Brief Description
    Lateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
  • Description
    Lateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Bassiatin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Elastase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65454-13-9
  • Formula Weight
    261.321
  • Molecular Formula
    C15H19NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)C1OC(=O)C(Cc2ccccc2)N(C)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hildreth, J.E.K. N-D-Gluco-N-methylalkanamide compounds, a new class of non-ionic detergents for membrane biochemistry. Biochem. J. 207(2), 363-366 (1982).
molnova catalog
related products
  • Ferric maltol

    Ferric maltol is a ferric, non-salt-based oral iron formulation demonstrating improved tolerance in patients with previous intolerance to other iron formulations.

  • KT-474

    KT-474 (KYM-001) is a PROTAC degrader targeting interleukin-1 receptor-associated kinase 4 (IRAK4) with antitumor activity for the study of autoimmune, inflammatory, and cardiovascular disease disorders.

  • Artemisinin

    Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria (as well as increasingly vivax malaria).